BioMarin Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionNeuberger Berman Group LLC
Latest Disclosed Ownership37,469 shares
Latest Disclosed Value $ 2,116,624
Neuberger Berman Group LLC ownership in BMRN / BioMarin Pharmaceutical Inc.

On May 14, 2026 - Neuberger Berman Group LLC filed a 13F-HR form disclosing ownership of 37,469 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $2,116,624 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 37,117 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 0.95% during the quarter. The current value of the position is $2,127,115 USD.

Neuberger Berman Group LLC has a history of taking positions in derivatives of the underlying security (BMRN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BMRN / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 37,469 352 0.95 2,117 -4.04 0.0016
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 37,117 7,345 24.67 2,206 36.79 0.0016
2025-11-12 2025-09-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 29,772 -1,985 -6.25 1,612 -7.62 0.0012
2025-08-25 2025-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL Common 09061G101 31,757 -64,410 -66.98 1,746 -74.33 0.0013
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 31,757 -64,410 1,746 0.0007
2025-05-13 2025-03-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 96,167 2,415 2.58 6,798 10.32 0.0057
2025-02-13 2024-12-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 93,752 -803,827 -89.56 6,162 -90.23 0.0049
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 897,579 -196,614 -17.97 63,091 -29.97 0.0492
2024-11-14 2024-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL Common 09061G101 1,094,193 628,463 134.94 90,085 121.47 0.0739
2024-08-13 2024-06-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 1,094,193 628,463 90,085 0.0739
2024-11-14 2024-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL Common 09061G101 465,730 117,008 33.55 40,677 20.98 0.0336
2024-05-13 2024-03-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 465,730 117,008 40,677 0.0336
2024-11-14 2023-12-31 13F/A-2 BIOMARIN PHARMACEUTICAL Common 09061G101 348,722 108,094 44.92 33,624 57.93 0.0293
2024-02-09 2023-12-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 348,722 108,094 33,624 0.0293
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 240,628 40,032 19.96 21,291 22.45 0.0194
2023-08-11 2023-06-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 200,596 46,549 30.22 17,388 16.08 0.0155
2023-05-12 2023-03-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 154,047 -14,975 -8.86 14,980 -14.37 0.0139
2023-02-13 2022-12-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 169,022 2,185 1.31 17,492 23.68 0.0171
2022-11-15 2022-09-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 166,837 139,356 507.10 14,143 521.12 0.0148
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 27,481 -242 -0.87 2,277 6.55 0.0023
2022-05-23 2022-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL Common 09061G101 27,723 -4,964 -15.19 2,137 -20.26 0.0018
2022-05-13 2022-03-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 27,723 -4,964 1,949 0.0009
2022-02-11 2021-12-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 32,687 5,442 19.97 2,680 36.80 0.0021
2021-11-12 2021-09-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 27,245 -5,386 -16.51 1,959 -24.04 0.0017
2021-08-13 2021-06-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 32,631 -4,570 -12.28 2,579 -5.77 0.0023
2021-05-13 2021-03-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 37,201 1,391 3.88 2,737 -12.22 0.0026
2021-02-10 2020-12-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 35,810 -42,171 -54.08 3,118 -47.44 0.0032
2020-11-12 2020-09-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 77,981 -7,344 -8.61 5,932 -43.63 0.0070
2020-08-13 2020-06-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 85,325 -118,187 -58.07 10,524 -38.80 0.0131
2020-05-14 2020-03-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 203,512 -3,419 -1.65 17,197 -1.71 0.0262
2020-02-12 2019-12-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 206,931 26,156 14.47 17,496 43.60 0.0204
2019-11-13 2019-09-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 180,775 -735,538 -80.27 12,184 -84.48 0.0149
2019-08-13 2019-06-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 916,313 -138,025 -13.09 78,482 -16.20 0.0939
2019-05-13 2019-03-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 1,054,338 -214,426 -16.90 93,657 -13.31 0.1148
2019-02-12 2018-12-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 1,268,764 -35,754 -2.74 108,035 -14.60 0.1506
2018-11-16 2018-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL Common 09061G101 1,304,518 116,452 9.80 126,499 13.03 0.1433
2018-11-13 2018-09-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 1,304,518 116,452 126,499
2018-08-13 2018-06-30 13F BIOMARIN PHARMACEUTICAL Common 09061G101 1,188,066 471,829 65.88 111,915 92.74 0.1235
2018-05-08 2018-03-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 716,237 411,140 134.76 58,065 113.43 0.0664
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL Common 09061G101 305,097 181,192 146.23 27,206 135.92 0.0313
2017-11-15 2017-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 123,905 -117,050 -48.58 11,532 -47.30 0.0144
2017-08-08 2017-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 240,955 79,759 49.48 21,884 54.66 0.0281
2017-05-10 2017-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 161,196 2,298 1.45 14,150 7.50 0.0183
2017-02-06 2016-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 158,898 -142,445 -47.27 13,163 -52.79 0.0177
2016-11-02 2016-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 301,343 684 0.23 27,880 19.19 0.0378
2016-08-05 2016-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 300,659 140,055 87.21 23,391 76.58 0.0322
2016-05-06 2016-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 160,604 -25,162 -13.54 13,247 -31.93 0.0182
2016-01-28 2015-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 185,766 -55,089 -22.87 19,461 -23.28 0.0255
2015-11-10 2015-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 240,855 577 0.24 25,367 -22.81 0.0327
2015-07-31 2015-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 240,278 -33,185 -12.14 32,865 -3.56 0.0365
2015-05-06 2015-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 273,463 273,463 0.00 34,079 0.0364
2015-02-05 2014-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 0 -534,277 -100.00 0 -100.00
2014-11-04 2014-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 534,277 -707,027 -56.96 38,553 -50.08 0.0396
2014-08-05 2014-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 1,241,304 -436,696 -26.02 77,222 -32.53 0.0754
2014-05-05 2014-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 1,678,000 425,778 34.00 114,456 29.92 0.1164
2014-02-11 2013-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 1,252,222 620,400 98.19 88,094 93.19 0.0906
2013-10-29 2013-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 631,822 368,287 139.75 45,599 210.43 0.0506
2013-08-13 2013-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 263,535 263,535 14,689 0.0175
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-25 2025-06-30 13F/A July 25 Calls on BMRN US Option Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-13 2025-06-30 13F July 25 Calls on BMRN US Option Call 0 0 n/a n/a n/a
2025-05-13 2025-03-31 13F July 25 Calls on BMRN US Option Call 2,899 30.35 957 44.63 n/a n/a n/a
2025-02-13 2024-12-31 13F April 25 Calls on BMRN US Option Call 2,224 662 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-13 2024-12-31 13F January 25 Puts on BMRN US Option Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F January 25 Puts on BMRN US Option Put 1,144 1,195 n/a n/a n/a
2024-11-14 2024-06-30 13F/A January 25 Puts on BMRN US Option Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-13 2024-06-30 13F January 25 Puts on BMRN US Option Put 0 0 n/a n/a n/a
2024-11-14 2024-03-31 13F/A January 25 Puts on BMRN US Option Put 722 617 n/a n/a n/a
2024-05-13 2024-03-31 13F January 25 Puts on BMRN US Option Put 722 617 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.